In this talk from the 2020 Advancing Excellence in Sexual and Gender Minority Health conference, Dr. Ken Mayer describes drivers for HIV/STI risk in LGBTQIA+ people, highlights current data around infections in the U.S., and provides recommendations and resources on how to prevent HIV/STI infection.
Learning Resources — Webinars filtered by Topic
In this talk from the 2020 Advancing Excellence in Sexual and Gender Minority Health conference, Julie Thompson describes barriers to care experienced by LGBTQIA+ communities, provides recommendations for talking about sex and bodies with cultural humility, and outlines a trauma-informed approach to care.
Dr. Kevin Ard and Dr. Jennifer Reske-Nielsen discuss HIV and PrEP in primary care and sexual health clinic settings, and the current state of HIV research and treatment in the United States.
Dr. Kevin Ard will use clinical cases to explore recent advances in HIV pre-exposure prophylaxis (PrEP) and sexually-transmitted infection prevention and treatment for LGBTQ people, discussing implications for primary and specialty care.
Dr. Kenneth Mayer discusses the biology, behaviors, social network structures, and societal structures that influence the risk factors for HIV transmission. Using this framework, Dr. Mayer explains how gender minority people are at higher risk for HIV transmission, particularly if they have intersecting marginalized identities. Dr. Mayer describes many ways in which providers can increase access to HIV treatment strategies for gender diverse people, including clinical strategies, online tools, and social tools. Dr. Mayer focuses on not having a "one size fits all" strategy, but rather understanding the needs of a particular patient and creating a treatment strategy specific to that person.
Kevin Ard, MD, MPH, discusses increasing rates of sexually-transmitted infections in the United States, and how these infections disproportionately burden LGBTQ people. In addition, transgender women and gay and bisexual men continue to face high burdens of HIV infection. This clinically-focused webinar will highlight state-of-the-art approaches to HIV and STI prevention for LGBTQ people, ranging from well-established interventions such as pre-exposure prophylaxis and vaccinations to novel strategies, including antibiotic post-exposure prophylaxis for STIs.
In this talk, JoAnne Keatley, MSW, discusses how transgender and non-binary communities are engaging in self-advocacy around HIV prevention, treatment, and research. Keatley focuses particularly on IRGT, a global network of transwomen and HIV, and how this international organization focuses on HIV prevention and treatment that is tailored to the particular needs of transgender women. Some of the other issues addressed by Keatley include how transmasculine people are working to have their identities acknowledged in data collection so that they are not grouped with cisgender men who have sex with men, how many transgender-led organizations are working to simultaneously address human rights issues alongside HIV work, and how peer-led education strategies can be extremely effective in combating HIV in transgender communities.
In this talk, Dr. Tonia Poteat discusses best practices for prescribing and using PrEP among transgender patients.
Rates of syphilis and gonorrhea have been increasing in the United States, and most cases occur in men who have sex with men (MSM). In this webinar, Dr. Kevin Ard will review recent trends in STIs and examine causes for these trends. He will also discuss the controversial impact of HIV pre-exposure prophylaxis (PrEP) on STI incidence among MSM. Dr. Ard will outline steps clinicians and health centers can take to address STIs in 2018.
The web-based CME/CEU is designed to assist health providers caring for transgender people, with a focus on transgender women. The program presents the latest data on transgender people and HIV, describes the roles stigma and discrimination play in contributing to health disparities, and provides tips on how to provide patient-centered care specific to the needs of transgender people. The program presents strategies to make clinical environments more welcoming to transgender patients and covers critical topics in HIV prevention and care—including PrEP (pre-exposure prophylaxis) and PEP (post-exposure prophylaxis); initiation of and adherence to ART (antiretroviral therapy); safer sexual behaviors; STDs (sexually transmitted diseases) and HIV; and other important topics such as drug interactions with affirming hormonal therapy, partner services, and referral resources.